Is MITO Stock A Buy Here?
In this article we will analyze whether Stealth BioTherapeutics Corp (NASDAQ:MITO) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their...
Stealth Biotherapeutics Corp (MITO)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 0 | $0 | 0% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is Stealth BioTherapeutics Corp (MITO) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Getting Interested In Stealth BioTherapeutics Corp (MITO)
In this article we will check out the progression of hedge fund sentiment towards Stealth BioTherapeutics Corp (NASDAQ:MITO) and determine whether it is a good investment right now.